The page is the record's research on the issuer — no analyst, no rating, no view.

Arbutus Biopharma Corp (ABUS) — research page

US · us-cm-kg/NASDAQ/ABUS · as of 2026-11-08

Identity and listing

Arbutus Biopharma Corp is listed on NASDAQ under the ticker ABUS, with ISIN US03879J1007. The record holds no LEI for the issuer, as no GLEIF record carries the exact legal name in jurisdiction US-A1. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is British Columbia, Canada. Its segment is not on the record. Its listing status is listed, not halted.

fieldvaluesource · read date
nameArbutus Biopharma Corpsource · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerABUSsource · 2026-11-08
ISINUS03879J1007source · 2026-10-14
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionBritish Columbia, Canadasource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 48 filings across 31 filing days in the window from 2025-11-08 to 2026-11-08. Filings by type are: directors' dealings 13, regulatory filing 11, corporate news 8, results 8, takeover 4, AGM/EGM 2, and director change 2. The median gap between filing days is 9.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is a regulatory filing dated 2026-10-27, 12 days before the record date. Median latency is 5.0 days for NASDAQ and 4.0 days for the sector, and median filings in the window are 52 for NASDAQ and 63.0 for the sector.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer48912
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-10-27regulatory_filingSCHEDULE 13G/ASCHEDULE 13G/A
2026-10-22corporate_news8-K8-K — FORM 8-K (items 8.01,9.01)
2026-10-07directors_dealings44 — FORM 4
2026-10-07directors_dealings44 — FORM 4
2026-10-07directors_dealings44 — FORM 4

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young LLP, located in Philadelphia, Pennsylvania. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

No openly published research notes were found. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record seals the issuer for the years 2021 through 2026. The market's vintage is sealed, with earliest sealed date 2021-01-04. The live record began on 2026-09-12.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001447028.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NASDAQ/ABUS (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://www.sec.gov/Archives/edgar/data/1447028/000144702826000017/abus-20251231.htm (the auditor)
10.7
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.us-cm-kg.ai/record/NASDAQ/ABUS (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US03879J1007"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:92057befa55060a9.